News & Events

Two market leaders join forces to meet the growing demand for high-quality histopathology and neuropathology services in the preclinical therapeutics market

The new brand and identity encapsulates the commitment of expansion and growth following the merger of Histo-Scientific Research Laboratories with Vet Path Services and investment from Ampersand Capital Partners

To commemorate the merger of two industry leaders in preclinical histology, pathology and specimen archiving, we are thrilled to announce the launch of our new website highlighting the full breadth of our capabilities and footprint, as well as the debut of our new brand!

Formation of company to meet growing demand for high-quality histopathology services in the research and pre-clinical therapeutics markets includes growth equity investment from Ampersand Capital Partners

Immunohistochemistry (IHC) and immunofluorescence (IF) are molecular assays that involve the use of antibodies to detect specific proteins within tissues on microscope slides

The ability to convert glass microscope slides to high resolution, digital images and then perform morphometric image analysis is an important part of many preclinical research and development studies.

IHC is a valuable tool that can be used during most phases of drug development.  It assists with target validation during early discovery projects and can help determine efficacy and safety during later phases of research and development.

Immunohistochemistry (IHC) is a molecular assay that involves the use of antibodies to detect specific proteins within tissues on microscope slides.  

Creating slides is one of the most critical components of histology labs, but ensuring quality can sometimes slip if dealing with staff shortages

The success of preclinical drug research often hinges upon investigator engagement.